A Novel Agonist Binding Site on Nicotinic Acetylcholine Receptors

References

• Grenningloh G., Rienitz A., Schmidt B., Methfessel C., Zensen M., Beyreuther K., Gundelfinger E. D., Betz H. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature (Lond.) 1987; 328: 215–220
   PubMed Web of Science ®Google Scholar
• Schofield P., Darlison M. G., Fujita N., Burt D., Stephenson F. A., Rodriquex H., Rhee L. M., Ramachandran J., Reale V., Glencorse T. A., Seeburg P. H., Barnard E. A. Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor superfamily. Nature (Lond.) 1987; 328: 221–227
   PubMed Web of Science ®Google Scholar
• Maelicke A., Fulpius B. W., Klett R. P., Reich E. Acetylcholine receptor: Responses to drug binding. J. Biol. Chem. 1977; 252: 4811–4830
   PubMed Web of Science ®Google Scholar
• Karlin A. Molecular properties of nicotinic acetylcholine receptors. The Cell Surface and Neuronal Function, C. W. Cotman, G. Poste, G. L. Nicolson. Biochemical Press, Amsterdam, North Holland 1980; 191–260
   Google Scholar
• Spivak C. E., Albuquerque E. X. The dynamic properties of the nicotinic receptor ionic channel complex: activation and blockade. Progress in Cholinergic Biology: Models of Cholinergic Synapses, I. Hanin, A. M. Goldberg. Raven Press, New York 1982; 323–357
   Google Scholar
• Albuquerque E. X., Daly J. W., Warnick J. E. Macromolecular sites for specific neurotoxins and drugs on chemosensitive synapses and electrical excitation in biological membranes. Ion Channels, T. Narahashi. Plenum Press, New York 1988; Vol. 1: 95–162
   Google Scholar
• Mishina M., Takai T., Imoto K., Noda M., Takahashi T., Numa S., Methfessel C., Sakmann B. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986; 321: 406–411
   PubMed Web of Science ®Google Scholar
• Neumann D., Barchan D., Fridkin M., Fuchs S. Analysis of ligand binding to the synthetic dodecapeptide 185–196 of the acetylcholine receptor α subunit. Proc. Natl. Acad. Sci. USA 1986; 83: 9250–9253
   PubMed Web of Science ®Google Scholar
• Lagenbuch-Cachat J., Bon C., Mulle C., Goeldner M., Hirth C., Changeux J.-P. Photoaffinity labeling of the acetylcholine binding sites on the nicotinic receptor by an aryldiazonium derivative. Biochemistry 1988; 27: 2346–2357
   PubMed Web of Science ®Google Scholar
• Spivak C. E., Waters J., Witkop B., Albuquerque E. X. Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors. Mol. Pharmacol. 1983; 23: 337–343
   PubMed Web of Science ®Google Scholar
• Swanson K. L., Allen C. N., Aronstam R. S., Rapoport H., Albuquerque E. X. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-Anatoxin-a. Mol. Pharmacol. 1986; 29: 250–257
   PubMed Web of Science ®Google Scholar
• Nambi-Aiyar V., Benn M. H., Hanna T., Jacyno J., Roth S. H., Wilkens J. L. The principal toxin of Delphinium brownii (Rydb.) and its mode of action. Experientia (Basel) 1979; 35: 1367–1368
   PubMedGoogle Scholar
• Macallan D. R. E., Lunt G. G., Wonnacott S., Swanson K. L., Rapoport H., Albuquerque E. X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 1988; 226: 357–363
   PubMed Web of Science ®Google Scholar
• Alkondon M., Pereira E. F. R., Wonnacott S., Albuquerque E. X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol. 1992; 41: 802–808
   PubMed Web of Science ®Google Scholar
• Aracava Y., Ikeda S. R., Daly J. W., Brookes N., Albuquerque E. X. Interactions of bupivacaine with the nicotinic receptor: Analysis of single-channel currents. Mol. Pharmacol. 1984; 26: 304–313
   PubMed Web of Science ®Google Scholar
• Neher E. The charge carried by single-channel currents of rat cultured muscle cells in the presence of local anesthetics. J. Physiol. (London) 1983; 339: 663–678
   Google Scholar
• Albuquerque E. X., Tsai M.-C., Aronstam R. S., Eldefrawi A. T., Eldefrawi M. E. Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol. Pharmacol. 1980; 18: 167–178
   PubMed Web of Science ®Google Scholar
• Ramoa A. S., Alkondon M., Aracava Y., Irons J., Lunt G. G., Deshpande S. S., Wonnacott S., Aronstam R. S., Albuquerque E. X. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J. Pharmacol. Exp. Ther. 1990; 254: 71–82
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Kuba K., Daly J. Effect of histrionicotoxin on the ionic conductance modulator of the cholinergic receptor: A quantitative analysis of the end-plate current. J. Pharmacol. Exp. Ther. 1974; 189: 513–524
   PubMed Web of Science ®Google Scholar
• Aronstam R. S., Eldefrawi A. T., Pessah I. N., Daly J. W., Albuquerque E. X., Eldefrawi M. E. Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J. Biol. Chem. 1981; 256: 2843–2850
   PubMed Web of Science ®Google Scholar
• El-Fakahany E. F., Miller E. R., Abbassy M. A., Eldefrawi A. T., Eldefrawi M. E. Alcohol modulations of drug binding to the channel of the nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 1983; 224: 284–296
   Web of Science ®Google Scholar
• Whiting P., Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. USA 1987; 84: 595–599
   PubMed Web of Science ®Google Scholar
• Boulter J., Connolly J., Deneris E., Goldman D., Heinemann S., Patrick J. Functional expression of two cDNA clones identifies a gene family. Proc. Natl. Acad. Sci. USA 1987; 84: 7763–7767
   PubMed Web of Science ®Google Scholar
• Duvoisin R. M., Deneris E. S., Patrick J., Heinemann S. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit:β4. Neuron 1989; 3: 487–496
   PubMed Web of Science ®Google Scholar
• Papke R. L., Boulter J., Patrick J., Heinemann S. Single-channel currents of rat neuronal acetylcholine receptors expressed in Xenopus oocytes. Neuron 1989; 3: 589–596
   PubMed Web of Science ®Google Scholar
• Aracava Y., Deshpande S. S., Swanson K. L., Rapoport H., Wonnacott S., Lunt G., Albuquerque E. X. Nicotinic acetylcholine receptors in cultured neurons from the hippocampus and the brain stem of the rat characterized by single channel recordings. FEBS Lett. 1987; 222: 63–70
   PubMed Web of Science ®Google Scholar
• Alkondon M., Albuquerque E. X. α-cobratoxin blocks the nicotinic acetylcholine receptor in rat hippocampal neurons. Eur. J. Pharmacol. 1990; 191: 505–506
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Costa A. C. S., Alkondon M., Shaw K. P., Ramoa A. S., Aracava Y. Functional properties of the nicotinic and glutamatergic receptors. J. Rec. Res. 1991; 11: 603–625
   PubMed Web of Science ®Google Scholar
• Alkondon M., Albuquerque E. X. Initial characterization of the nicotinic acetylcholine receptors in rat hippocampal neurons. J. Rec. Res. 1991; 11: 1001–1022
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Alkondon M., Lima-Landman M. T., Deshpande S. S., Ramoa A. Molecular targets of noncompetitive blockers at central and peripheral nicotinic and glutamatergic receptors. Neuromuscular Junction, L. C. Sellin, R. Libelius, S. Thesleff. Elsevier Science Publishers, New York 1988; 273–300
   Google Scholar
• Lipton S. A., Aizeman E., Loring R. H. Neural nicotinic acetylcholine responses in solitary mammalian retinal ganglion cells. Pflügers Arch. 1987; 410: 37–43
   PubMed Web of Science ®Google Scholar
• Berg D. K., Boyd R. T., Halvorsen S. W., Hoggins L. S., Jacob M. H., Margiotta J. F. Regulating the number and function of neuronal acetylcholine receptors. TiNS 1989; 12: 16–21
   PubMed Web of Science ®Google Scholar
• Mulle C., Changeux J.-P. A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp technique. J. Neurosci. 1990; 10: 169–175
   PubMed Web of Science ®Google Scholar
• Couturier S., Bertrand D., Matter J.-M., Hernandez M.-C., Bertrand S., Millar N., Valera S., Barkas T., Balivet M. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homooligomeric channel blocked by α-BTX. Neuron 1990; 5: 847–856
   PubMed Web of Science ®Google Scholar
• Pereira E. F. R., Wonnacott S., Albuquerque E. X. Methyllycaconitine (MLA) is a potent antagonist of nicotinic acetylcholine receptors (nAChR) on rat hippocampal neurons: Single channel studies. Soc. Neurosci. Abs. 1991; 17: 960
   Google Scholar
• Gordon J. J., Leadbeater L., Maidment M. P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 1978; 43: 207–216
   PubMed Web of Science ®Google Scholar
• Deshpande S. S., Viana G. B., Kauffman F. C., Rickett D. L., Albuquerque E. X. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Fundam. Appl. Toxicol. 1986; 6: 566–577
   PubMedGoogle Scholar
• Thal L. J., Fuld P. A., Masur D. M., Sharpless N. S. Oral physostigmine and lecithin improve memory in Alzheimer's disease. Ann. Neurol. 1983; 13: 491–496
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Deshpande S. S., Kawabuchi M., Aracava Y., Idriss M., Rickett D. L., Boyne A. F. Multiple actions of anticholinesterase agents on chemosensitive synapses: Molecular basis for prophylaxis and treatment of organophosphate poisoning. Fund. Appl. Toxicol. 1985; 5: S182–S203
   Google Scholar
• Albuquerque E. X., Aracava Y., Idriss M., Schonenberger B., Brossi A., Deshpande S. S. Activation and blockade of the nicotinic and glutamatergic synapses by reversible and irreversible cholinesterase inhibitors. Neurobiology of Acetylcholine, N. J. Dun, R. L. Perlman. Plenum Press, New York 1987; 301–328
   Google Scholar
• Shaw K.-P., Aracava Y., Akaike A., Daly J. W., Rickett D. L., Albuquerque E. X. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 1985; 28: 527–538
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Aracava Y., Cintra W. M., Brossi A., Schonenberger B., Deshpande S. S. Structure-activity relationship of reversible of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel. Braz. J. Med. Biol. Res. 1988; 21: 1173–1196
   PubMed Web of Science ®Google Scholar
• Akaike A., Ikeda S. R., Brookes N., Pascuzzo G. J., Rickett D. L., Albuquerque E. X. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine-receptor ion channel complex II. Patch clamp studies. Mol. Pharmacol. 1984; 25: 102–112
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Akaike A., Shaw K.-P., Rickett D. L. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex. Fundam. Appl. Toxicol. 1984; 4: S27–S33
   PubMedGoogle Scholar
• Okonjo K. O., Kuhlmann J., Maelicke A. A second pathway for the activation of the Torpedo acetylcholine receptor. Eur. J. Biochem. 1991; 200: 671–677
   PubMedGoogle Scholar
• Maelicke A., Coban T., Conti-Tronconi B. M., Diethelm B., Hendlinger P., Methfessel C., Okonjo K. O., Pereira E. F. R., Schrattenholz A., Schroeder B., Albuquerque E. X. Physostigmine and neuromuscular transmission. Ann. N. Y. Acad. Sci. 1992, submitted
   Google Scholar
• Kuhlmann J., Okonjo K. O., Maelicke A. Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel. FEBS Lett. 1991; 279: 216–218
   PubMed Web of Science ®Google Scholar
• Cavallito C. J., Foldes F. F. Molecular interaction and modulation of adverse actions of muscle relaxants in anesthesiology. Drug Metabol. Rev. 1984; 15: 591–618
   PubMed Web of Science ®Google Scholar
• Tano T., Maelicke A., Aronstam R. S., Albuquerque E. X. Benzoquinonium (BZQ) interactions with peripheral nicotinic acetylcholine receptors (AChR): Electrophysiological and biochemical studies. Soc. Neurosci. Abs. 1991; 17: 1527
   Google Scholar
• Tano T., Maelicke A., Aronstam R. S., Albuquerque E. X. Interactions of benzoquinonium with muscle nicotinic acetylcholine receptors, In preparation
   Google Scholar
• Albuquerque E. X., Barnard E. A., Porter C. W., Warnick J. E. The density of acetylcholine receptors and their sensitivity in the postsynaptic membrane of muscle endplates. Proc. Natl. Acad. Sci. USA 1974; 71: 2818–2822
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Gage P. W. Differential effects of perhydrohistrionicotoxin on neurally and iontophoretically evoked endplate currents. Proc. Natl. Acad. Sci. USA 1978; 75: 1596–1599
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Gage P. W., Oliveira A. C. Differential effect of perhydrohistrionicotoxin on “intrinsic” and “extrinsic” end-plate responses. J. Physiol. (Lond.) 1979; 297: 423–442
   Google Scholar
• Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 1981; 391: 85–100
   PubMed Web of Science ®Google Scholar
• Sachs F., Neil J., Barkakati N. The automated analysis of data from single ionic channels. Pflügers Arch. 1982; 395: 331–340
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Maelicke A., Pereira E. F. R. Single channel currents activated by physostigmine (PHY) in hippocampal neurons are blocked by benzoquinonium (BZQ) but not by methyllycaconitine (MLA). Soc. Neurosci. Abs. 1991; 17: 585
   Google Scholar
• Pereira E. F. R., Maelicke A., Albuquerque E. X. (-)Physostigmine directly activates nicotinic acetylcholine receptors of cultured hippocampal neurons, In preparation
   Google Scholar
• Sherby S. M., Eldefrawi A. T., Albuquerque E. X., Eldefrawi M. E. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Mol. Pharmacol. 1985; 27: 343–348
   PubMed Web of Science ®Google Scholar
• Deshpande S. S., Albuquerque E. X. Effect of (-)Physostigmine (PHY) and narcotic antagonist (+)benzylcarbamoyleseroline (BCE) on NMDA and quisqualate receptors in mammalian brain. Soc. Neurosci. Abs. 1988; 14: 97
   Google Scholar
• Schrattenholz A., Godovac-Zimmermann J., Schafer H.-J., Albuquerque E. X., Maelicke A. Photoaffinity labeling of Torpedo acetylcholine receptor by the reversible cholinesterase inhibitor physostigmine. Proc. Natl. Acad. Sci. USA. 1992, submitted
   Google Scholar
• Adler M., Albuquerque E. X., Lebeda F. J. Kinetic analysis of endplate currents altered by atropine and scopolamine. Mol. Pharmacol. 1978; 14: 514–529
   PubMed Web of Science ®Google Scholar